Tag: Her2Overexpressing

Her2+ breast cancer: Breast cancer that overexpresses the HER2/neu gene.

Articles

News

05/20/17
Muscadine grape extract reduces HER2+ breast cancer cell proliferation
02/26/17
Ursolic acid causes death of various types of breast cancer cells
05/01/16
Six-month delay in starting Herceptin linked to reduced survival in HER2+ breast cancer
10/31/15
Parabens may be harmful at lower levels than previously thought in ER+/PR+/HER2+ cells
08/22/15
Dietary sugar promotes breast cancer development and metastasis
05/23/15
Sulforaphane inhibits Herceptin-resistant Her2+ tumor growth and reduces triple negative breast cancer stem cell populations
07/20/14
HER2 status of lymph nodes can differ from that of primary breast tumor
06/14/14
Apigenin triggers death of HER2 overexpressing breast cancer cells
01/28/14
Folic acid promotes tumor progression in animal model of breast cancer
10/31/13
Poor glucose control could reduce metformin's anti-cancer benefits
05/31/13
Black pepper compound increases effectiveness of Taxol against HER2+ breast cancer
04/28/13
High circulating insulin levels increase HER2+ tumor size and metastases in mice
01/20/13
Triple negative and some HER2+ subtypes have up to 11% rate of locoregional recurrence after mastectomy
12/27/12
Fish oil inhibits early stages of HER-2 tumor development
09/08/12
Pomegranate extract inhibits proliferation of HER2+ and triple negative breast cancer
08/07/12
Watercress compound reduces tumor growth in mouse model of HER2+ breast cancer
07/22/12
Inflammation can contribute to resistance to Herceptin
05/24/12
Multifocal breast cancer is treated less successfully than unifocal breast cancer
05/13/12
A story of long-term stage IV HER2+ breast cancer survival
04/19/12
Green tea polyphenol EGCG slows development of tamoxifen resistance
04/12/12
Five-year prognosis by breast cancer subtype
01/18/12
High intake of soy isoflavones increases risk of recurrence in HER2+ patients
01/17/12
Apigenin increases effectiveness of Taxol chemotherapy
12/13/11
Metformin improves survival of diabetic women with HER2+ breast cancer
12/02/11
Knowing the receptor status of metastases improves treatment decisions
12/01/11
Herceptin plus anthracycline chemotherapy greatly increases risk of heart damage
10/22/11
Young breast cancer patients require aggressive treatment
10/20/11
Age and breast cancer subtype influence prognosis after lumpectomy
10/17/11
Alcohol promotes premenopausal HER2+ tumor development in a mouse model of HER2+ breast cancer
10/13/11
Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
10/06/11
Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
09/27/11
Hormone receptor status changes during progression in over one-third of breast cancer cases
09/22/11
Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
08/01/11
Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
06/21/11
Low carbohydrate, high protein diet inhibits mammary tumor growth and development in mice
06/05/11
High C-reactive protein (CRP) levels linked to unfavorable breast cancer prognosis
06/03/11
Likelihood of late recurrence for hormone receptor positive breast cancer is hard to predict
05/14/11
Blood type is not related to breast cancer outcomes
05/09/11
Curcumin and DHA act synergistically in hormone receptor negative HER2+ breast cancer
05/05/11
Measles virus may be associated with breast cancer
04/25/11
Low circulating vitamin D is associated with more aggressive breast cancer
03/30/11
Although similar, ER+/PR- breast cancer is more aggressive than ER+/PR+
03/27/11
Circulating tumor cells in breast cancer patients linked to poor prognosis
03/19/11
Treatment with Herceptin for one year improves survival in women with HER2+ breast cancer
03/02/11
Risk of second primary breast cancer highest in hormone receptor negative survivors
02/20/11
Effectiveness of MRI in monitoring effectiveness of chemotherapy depends on subtype
01/27/11
Obesity is linked to inferior prognosis for hormone receptor positive breast cancer
12/29/10
Old women tend to have less aggressive breast cancer and are given less treatment
12/17/10
Cigarette smoking reduces breast cancer survival
11/28/10
Erythropoietin for anemia may hinder Herceptin treatment for HER2-positive breast cancer
11/21/10
Black rice compound induces breast cancer cell death and suppresses angiogenesis
10/23/10
Asian-American women have higher rates of HER2-positive breast cancer than Caucasians
09/14/10
Does a family history of breast cancer increase the risk of certain subtypes?
09/12/10
Breast cancer prognosis - risk of locoregional recurrence by breast cancer subtype
09/09/10
Flaxseed enhances Herceptin treatment in mouse model of HER2 breast cancer
07/17/10
Oleic acid promotes breast cancer cell invasiveness
07/07/10
Follow-up after breast cancer should take into account risk of relapse
02/03/10
Characteristics of breast cancer in women under 40
01/05/10
Pomegranate compounds inhibit aromatase and reduces breast cancer cell proliferation
01/03/10
Black women less likely to survive ER+/PR+ breast cancer - what to do

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap